| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2018 | Apr 18, 2018 | Garanzini Michael Chief Commercial Officer | Buy | Eyegate Pharmaceuticals Inc | EYEG | ~ | $0 | +47.71% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.